GALNF (Galenica) Moat Score: 4/10 (As of Jun. 25, 2026)


GALNF Galenica Ltd GALNF
80 GF Score
Price $115.00
GF Value $117.23
! 1 Warning Sign
View Full Analysis

What is Galenica Moat Score?

Galenica GALNF 80 Moat Score is 4 as of Jun. 25, 2026. GuruFocus rates GALNF with a GF Score™ of 80/100 and a GF Value™ of $117.23. The stock has 1 warning sign investors should review. Among 121 Medical Distribution companies, Galenica ranks better than 90.08% on this metric.

Galenica has the Moat Score of 4, which implies that the company might have Narrow Moat - Discernible but modest moat.

Galenica has Narrow Moat: Galenica benefits from a strong distribution network and some regulatory barriers in the healthcare sector. However, its market share and brand strength are not sufficient to elevate it beyond a modest moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Galenica might have Narrow Moat - Discernible but modest moat.

Galenica  (OTCPK:GALNF) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Galenica Moat Score Related Terms

GALNF vs MCK, COR, CAH: Moat Score Comparison

For the Medical Distribution subindustry, Galenica's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Galenica Moat Score vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Galenica's Moat Score distribution charts can be found below:

* The bar in red indicates where Galenica's Moat Score falls into.


GALNF
80GF Score
Galenica Ltd GALNF
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 4 mean?
Galenica (GALNF) has a Moat Score of 4 as of Jun. 25, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Galenica ranks #12 out of 121 companies in the Medical Distribution industry, placing it in the top 9.9%.
Is Galenica's Moat Score too high?
Galenica's current Moat Score is 4. Based on the distribution chart, Galenica ranks #12 out of 121 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Galenica has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Galenica's Moat Score compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Galenica ranks #12 out of 121 companies for Moat Score. This places Galenica in the top 10% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Distribution company?
A good Moat Score depends on the Medical Distribution industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Galenica's current Moat Score is 4. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Galenica stock overvalued right now?
Galenica (GALNF) has a current Moat Score of 4. The stock's GF Value™ is $117.23, compared to a current price of $115.00 — trading 1.9% below its estimated fair value. The current Moat Score is 4. Galenica's overall GF Score™ is 80/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Galenica (GALNF), the current Moat Score is 4 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Galenica (GALNF) Overvalued in 2026?

Based on GuruFocus' analysis, Galenica stock appears to be undervalued. The current stock price of $115.00 is trading 1.9% below its estimated GF Value™ of $117.23.

Key valuation signals for GALNF:

  • Moat Score: 4
  • GF Value™: $117.23 vs. price of $115.00 (1.9% below fair value)
  • GF Score™: 80/100 with 1 warning sign

No single metric tells the full story. See the GALNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Galenica Business Description

Address Untermattweg 8, Bern, CHE, CH-3027
Galenica Ltd is an integrated healthcare service provider in Switzerland. The business is operated from two segments Products & Care and Logistics & IT. The Products & Care segment comprises the Retail business area with offerings for patients and end customers and the Professionals business area with offerings for business customers and partners in the healthcare sector. The Logistics & IT segment comprises the two sectors Wholesale and Logistics & IT Services. These provide services for all those involved in the healthcare sector - pharmacies, drugstores, doctors, hospitals and care homes, partners, and suppliers. Geographically, it operates in Switzerland and Other Countries.
80GF Score

Get the complete analysis for GALNF

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$115.00
Price
$117.23
GF Value